Andrew Obenshain, President and CEO at bluebird bio, Inc. (BLUE), sold 43,610 shares at $4.39 ($191K) on 2022-08-04, disclosed to the SEC on 2022-08-08.
Open-market sale of $191k BLUE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.39 | 21,805 | $96K | 50.0% |
| 2 | $4.39 | 21,805 | $96K | 50.0% |
| Total | $4.39 avg | 43,610 | $191K | 100% |
| Filing → |
| BLUE | SELL | 2025-01-08 | $1K | — | Filing → |
| BLUE | SELL | 2024-12-12 | $408 | — | Filing → |
| BLUE | SELL | 2024-10-02 | $18K | — | Filing → |